ASX - By Stock
|
IMM |
Re:
EFTI at 90
|
|
Runaway2020
|
42 |
15K |
0 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
42
|
15K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
EFTI at 90
|
|
Runaway2020
|
42 |
15K |
3 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
42
|
15K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
EFTI at 90
|
|
Runaway2020
|
42 |
15K |
13 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
42
|
15K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
EFTI at 90
|
|
Runaway2020
|
42 |
15K |
3 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
42
|
15K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive initial data in phase 2 Soft Tissue Sarcoma trial
|
|
Runaway2020
|
16 |
7.6K |
1 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
16
|
7.6K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
330K |
21 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
743
|
330K
|
21
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
Runaway2020
|
51 |
23K |
21 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
51
|
23K
|
21
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
Runaway2020
|
56 |
30K |
5 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
56
|
30K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.6K |
1.0M |
6 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
2.6K
|
1.0M
|
6
|
|
ASX - By Stock
|
IMM |
Re:
An obsevation re Eftiligomab alfa
|
|
Runaway2020
|
24 |
8.4K |
4 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
24
|
8.4K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
An obsevation re Eftiligomab alfa
|
|
Runaway2020
|
24 |
8.4K |
1 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
24
|
8.4K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
An obsevation re Eftiligomab alfa
|
|
Runaway2020
|
24 |
8.4K |
2 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
24
|
8.4K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
330K |
0 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
743
|
330K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Notification regarding unquoted securities - IMM
|
|
Runaway2020
|
3 |
1.6K |
0 |
04/02/24 |
04/02/24 |
ASX - By Stock
|
3
|
1.6K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
330K |
11 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
743
|
330K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
330K |
5 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
743
|
330K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
330K |
1 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
743
|
330K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
330K |
4 |
28/01/24 |
28/01/24 |
ASX - By Stock
|
743
|
330K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.6K |
1.0M |
4 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
2.6K
|
1.0M
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.6K |
1.0M |
12 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
2.6K
|
1.0M
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.6K |
1.0M |
3 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
2.6K
|
1.0M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
330K |
1 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
743
|
330K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.6K |
1.0M |
15 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Only a matter of time
|
|
Runaway2020
|
19 |
10K |
7 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
19
|
10K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Interesting article in Saturday Telegraph relating to Keytruda.
|
|
Runaway2020
|
13 |
7.2K |
3 |
10/12/23 |
10/12/23 |
ASX - By Stock
|
13
|
7.2K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives A$2.6 million French R&D Tax Incentive
|
|
Runaway2020
|
8 |
3.5K |
11 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
8
|
3.5K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
330K |
4 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
743
|
330K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
330K |
14 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
743
|
330K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
330K |
14 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
743
|
330K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
330K |
4 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
743
|
330K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
330K |
9 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
743
|
330K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.6K |
1.0M |
8 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.6K |
1.0M |
0 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep reports promising data from INSIGHT-003 trial
|
|
Runaway2020
|
10 |
5.3K |
10 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
10
|
5.3K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.6K |
1.0M |
3 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
330K |
12 |
15/10/23 |
15/10/23 |
ASX - By Stock
|
743
|
330K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Commercial Scale Manufacturing of Efti for Clinical Trials
|
|
Runaway2020
|
29 |
12K |
3 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
29
|
12K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.6K |
1.0M |
1 |
17/09/23 |
17/09/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
330K |
2 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
743
|
330K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
330K |
9 |
27/08/23 |
27/08/23 |
ASX - By Stock
|
743
|
330K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Ann: 1st Patient Dosed in Phase 2 Soft Tissue Sarcoma Trial
|
|
Runaway2020
|
5 |
2.5K |
4 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
5
|
2.5K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.6K |
1.0M |
1 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.6K |
1.0M |
5 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.6K |
1.0M |
2 |
24/06/23 |
24/06/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.6K |
1.0M |
4 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Runaway2020
|
2.6K |
1.0M |
6 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Runaway2020
|
743 |
330K |
6 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
743
|
330K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
Runaway2020
|
37 |
12K |
2 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
37
|
12K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Seeks Trading Halt
|
|
Runaway2020
|
5 |
2.1K |
2 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
5
|
2.1K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: A$80 million fully underwritten equity raising
|
|
Runaway2020
|
57 |
25K |
0 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
57
|
25K
|
0
|
|